Insight

Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma

Photo of David Cordas dos Santos from connects.catalyst.harvard.edu

Jul 24, 2024, 08:12

Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma

Nature Medicine shared on X about a paper titled “A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy” published on their journal.

Authors: David M. Cordas dos Santos, Tobias Tix, Roni Shouval, Anat Gafter-Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff, Sebastian Theurich, Michael von Bergwelt-Baildon, Irene M. Ghobrial, Marion Subklewe, Miguel-Angel Perales and Kai Rejeski.

“In a meta-analysis of non-relapse mortality post-CAR-T cells in patients with lymphoma and myeloma, almost 1/2 of cases were caused by pathogens and mortality estimates varied across tumor types and CAR-T cell products.”

Source: Nature Medicine/X

Anat Gafter-Gvili cancer CAR T-CELL David M. Cordas dos Santos Edward R. Scheffer Cliff Irene M. Ghobrial Jean-Baptiste Alberge Kai Rejeski lymphoma Marion Subklewe Michael von Bergwelt-Baildon Miguel-Angel Perales Myeloma Nature Medicine OncoDaily Oncology Roni Shouval Sebastian Theurich Tobias Tix

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage